News & Events
- Cardinal Health’s Kangaroo OMNI™ Enteral Feeding Pump to launch in new international markets in 2025
- European Commission launches new Biotech and Biomanufacturing Hub
- FlyPharma 2025 Amsterdam officially announced as contracts are signed with host sponsors
- Prenatal care could be revolutionised suggests studies from BrightHeart
- CANDOR Bioscience acquired by Medix Biochemica
- MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients
- Bayer UK Launches New CanesMeno® Educational Hub and Product Range to Transform Menopause Support
- NICE issues positive final guidance for treatment of Duchenne Muscular Dystrophy from Santhera
- Positive topline results announced in phase 2 Alcohol Use Disorder study
- Results from Novadip phase 1b/2a trial reveal 88% efficacy
- Jérôme Berger announced as strategy and finance executive at Vect-Horus
- Research collaboration announced between Oxford University and GSK
- Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery
- Combination first-in-line treatment approved for patients with non-small cell lung cancer
- Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris
- Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first project
- First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark
- Uniphar appoints new global head of Scientific Communications
- Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0
- David Loose appointed CEO of Essex Management
